Category Archives: AZBio News

In memoriam: Linda Hunt

Posted on by

Linda Ann St. Pierre Hunt passed away very peacefully on May 17, 2025 at Sherman Home, Hospice of the Valley in Phoenix with her brother Raymond St. Pierre by her side. Linda courageously battled cancer for the past few years as well as other health-related challenges.Continue reading→

Whole-Person Genomics: New Partnership Tackles Rare Disease and Serious Mental Illness by Linking DNA Insights with Community Social Support Networks

Posted on by

TUCSON, AZ – UGenome AI, a pioneer in genomic technology, today announced an expanded partnership with Jura Health, Inc. to integrate both pharmacogenomic and nutrigenomic insights into the diagnosis of rare diseases and the development of personalized care plans. By combining expertise in whole genome sequencing (WGS), drug-gene interactions, and nutrient- gene relationships, the collaboration is designed to help rare disease patients receive earlier diagnoses, safer treatments, and lifestyle guidance tailored to their DNA.Continue reading→

Critical Path Institute and Citizen Health Partner to Accelerate Drug Development for Neuromuscular Disorders

Posted on by

SAN FRANCISCO and TUCSON, Ariz., May 29, 2025 — Critical Path Institute® (C-Path), a global nonprofit accelerating drug development through data science and regulatory innovation, and Citizen Health, a leading consumer health platform, today announced their new strategic collaboration. Together, the organizations will establish a partnership focused on neuromuscular disorders, including limb-girdle muscular dystrophies (LGMDs), Charcot-Marie-Tooth (CMT) disease, nemaline myopathy (NM), myotonic dystrophies, and related conditions.Continue reading→

CEO Forums: An FDA Listening Tour to Engage Pharma CEOs

Posted on by

The U.S. Food and Drug Administration is conducting a national listening tour to meet directly with pharmaceutical and biotech CEOs. Held in major innovation hubs across the country, the CEO Forums will be led by FDA Commissioner Marty A. Makary, M.D., M.P.H., along with Principal Deputy Commissioner Sara Brenner, M.D., M.P.H and Director of FDA’s Center for Biologics Evaluation and Research, Vinay Prasad, M.D., M.P.H.Continue reading→

ASU partners with biotech luminary and alum Mark McKenna to launch preeminent life science business program

Posted on by
  • Future health care leaders and innovators will accelerate their path through the McKenna Life Sciences, Business and Entrepreneurship Program, enabling the next generation of biotech game changers.
  • A cross-college collaboration between the W. P. Carey School of Business and The College of Liberal Arts and Sciences, the program reflects ASU’s decade-long status as America’s most innovative university.
  • The program will launch in 2026 through a generous gift from Mark and Sheri McKenna.

Continue reading→

Study says original COVID-19 vaccination did not stop immune system from fighting variants

Posted on by
  • Vaccinated people generated an overall protective immune response to the Delta and Omicron strains of COVID-19, though with slightly fewer antibodies for the mutated parts of the virus.
  • University of Arizona Health Sciences researchers found that people who received the original COVID-19 vaccine had greater antibody production against the Delta and Omicron variants than those who were unvaccinated.
  • Prior COVID-19 vaccination did not stop the immune system from mounting a protective response to the Delta and Omicron strains, though new mutation-specific antibody production dipped slightly, according to a study led by researchers at the University of Arizona Health Sciences and published in Nature Immunology.

Continue reading→